rss
J Neurol Neurosurg Psychiatry 2003;74:715-719 doi:10.1136/jnnp.74.6.715
  • Paper

Alzheimer’s disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia

  1. P M Kemp1,
  2. C Holmes2,
  3. S M A Hoffmann3,
  4. L Bolt3,
  5. R Holmes4,
  6. J Rowden2,
  7. J S Fleming3
  1. 1Department of Nuclear Medicine, Southampton University Hospitals Trust, Southampton, UK
  2. 2Memory Assessment and Research Centre, Moorgreen Hospital, Southampton, UK
  3. 3Department of Medical Physics and Bioengineering, Southampton University Hospitals Trust
  4. 4Department of Medical Physics and Bioengineering, Bristol Royal Infirmary, Bristol, UK
  1. Correspondence to:
 Dr P M Kemp, Department of Nuclear Medicine, Southampton University Hospitals Trust, Southampton, Hampshire, United Kingdom; 
 paul.kemp{at}suht.swest.nhs.uk
  • Received 10 September 2002
  • Revised 17 January 2003

Abstract

Objective: To compare the HMPAO SPECT cerebral perfusion patterns in early and late onset Alzheimer’s disease.

Methods: Twenty patients with early onset disease (<65 years) and 44 patients with late onset disease (>65 years) were studied. All patients fulfilled NINCDS-ADRDA clinical criteria and had details of disease severity and length of history at the time of imaging. Technetium-99m HMPAO SPECT brain scans were acquired on a multi-detector gammacamera and analysed visually and with statistical parametric mapping (SPM99).

Results: Patients with early onset disease had significantly greater posterior cortical association area involvement whereas those with late onset disease had significantly greater medial temporal hypoperfusion. These findings were unchanged after controlling for disease severity and length of illness.

Discussion: These functional imaging findings of the differences between early and late onset Alzheimer’s disease are supported by published findings that include histopathological and clinical evidence; namely late onset patients tend to present with the characteristic involvement of the medial temporal lobes producing marked memory loss whereas early onset patients present with predominant posterior cortical association area involvement. These age related findings should be borne in mind when clinically diagnosing, and interpreting functional brain imaging studies in, patients with suspected Alzheimer’s disease.

Footnotes

  • Competing interests: PMK has participated in European multi-centre trials and received research sponsorship from Amersham Health, manufacturer of HMPAO (Ceretec).

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs